Qualigen Therapeutics' Pan-RAS Inhibitor Program Highlighted

Qualigen Therapeutics' Pan-RAS Inhibitor Program Highlighted in Two Abstracts at American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

Qualigen Therapeutics' Pan-RAS Inhibitor Program Highlighted in Two Abstracts at American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Chicago , Illinois , American , Michael Poirier , University Of Louisville Uofl Research Foundation , Qualigen Therapeutics Inc , Jules Abrahamjqa Partners Inc , Qualigen Inc , Aboutqualigentherapeutics Inc , University Of Louisville , American Society Of Clinical Oncology , Nasdaq , Wall Street , Feature Preclinicaldata , Pancreatic Cancer , Luminalb Breast , Orphan Drug Designation , American Society , Clinical Oncology , Meeting Abstract , Meeting Abstract Book , Qualigen Therapeutics ,